Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
TRIP.COM-S
09961
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 63.32%6.61B | 76.68%4.15B | 55.01%1.45B | 13.71%6.32B | 19.09%4.05B | 0.19%2.35B | -10.17%934.56M | 35.95%5.55B | 14.28%3.4B | 21.81%2.34B |
| Refunds of taxes and levies | -22.52%160.48M | 48.49%160.48M | 44.11%153.87M | 100.48%217.82M | 91.46%207.12M | 112.72%108.08M | 6,509,071.74%106.77M | 4.95%108.65M | 4.72%108.18M | 48.49%50.81M |
| Cash received relating to other operating activities | -79.58%63.16M | -89.77%30.9M | -90.69%27.88M | 94.94%279.62M | 336.93%309.25M | 608.16%301.98M | 965.12%299.56M | 51.43%143.44M | 40.72%70.78M | 6.87%42.64M |
| Cash inflows from operating activities | 49.74%6.83B | 57.34%4.34B | 21.59%1.63B | 17.34%6.81B | 27.57%4.56B | 13.18%2.76B | 25.50%1.34B | 35.54%5.81B | 14.39%3.58B | 21.97%2.44B |
| Goods services cash paid | 22.42%6.32B | 17.36%3.99B | 50.16%1.98B | 65.56%7.52B | 90.14%5.17B | 92.84%3.4B | 60.04%1.32B | 5.37%4.54B | -10.77%2.72B | -3.25%1.76B |
| Staff behalf paid | 23.34%203.24M | 26.55%135.95M | 19.43%70.18M | -6.64%224.29M | -8.67%164.78M | -13.34%107.43M | -13.22%58.76M | 16.87%240.24M | 23.05%180.43M | 30.22%123.96M |
| All taxes paid | 60.49%153.27M | 75.13%113.86M | 42.22%25.65M | -0.53%219.24M | -25.82%95.5M | -11.24%65.01M | -70.09%18.03M | 3.89%220.41M | -5.53%128.75M | -13.46%73.25M |
| Cash paid relating to other operating activities | 29.60%75.71M | -11.86%40.49M | -35.92%23.35M | -22.73%108.07M | -13.89%58.42M | 22.66%45.93M | -42.78%36.44M | 46.31%139.85M | -9.23%67.84M | -54.85%37.45M |
| Cash outflows from operating activities | 23.19%6.76B | 18.30%4.28B | 46.60%2.09B | 56.95%8.07B | 77.27%5.48B | 81.12%3.62B | 40.95%1.43B | 6.60%5.14B | -9.07%3.09B | -4.19%2B |
| Net cash flows from operating activities | 108.63%79.32M | 106.46%55.73M | -427.15%-464.41M | -288.12%-1.25B | -289.86%-919.56M | -297.26%-862.7M | -261.16%-88.1M | 223.98%666.5M | 276.77%484.34M | 592.77%437.34M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 22.18%490.46M | -32.87%269.46M | -62.15%151.92M | 8.67%815M | -38.24%401.41M | -10.80%401.41M | 33.80%401.41M | -22.05%750M | -32.47%650M | -53.25%450M |
| Cash received from returns on investments | 4,091.64%37.71M | 1,647.94%11.52M | 1,513.19%10.63M | -86.37%1.89M | -93.46%899.56K | -76.68%658.88K | -59.37%658.88K | -61.63%13.84M | -62.36%13.76M | -92.10%2.83M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 373.81%7.16K | --7.16K | ---- | -99.85%1.51K | -99.83%1.51K | ---- | ---- | --990.04K | --886.15K | --886.15K |
| Cash received relating to other investing activities | -99.33%590.23K | -99.44%495.06K | -99.43%495.06K | 4.55%17.07M | 32.22%88.54M | 32.16%88.49M | 53.38%86.71M | -63.25%16.33M | 569.63%66.96M | 569.63%66.96M |
| Cash inflows from investing activities | 7.72%528.76M | -42.62%281.48M | -66.64%163.04M | 6.76%833.96M | -32.91%490.85M | -5.78%490.56M | 36.44%488.78M | -25.08%781.16M | -27.50%731.61M | -48.36%520.67M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -55.07%246.45M | -64.87%166.82M | -53.85%147.8M | -42.61%735.72M | -44.89%548.46M | -33.06%474.94M | -16.25%320.25M | -50.26%1.28B | -43.62%995.18M | -43.29%709.51M |
| Cash paid to acquire investments | 42.63%670M | 351.36%360M | -7.41%60M | -30.94%554M | 128.04%469.76M | -20.24%79.76M | --64.8M | 16.71%802.2M | 60.55%206M | -22.06%100M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.49M | --1.49M | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | 1,575.40%68.4M | 2,822.75%301.34M | 2,751.25%293.97M | 365.50%283.73M | -96.87%4.08M | -83.82%10.31M | -86.69%10.31M |
| Cash outflows from investing activities | -30.55%916.45M | -37.92%526.82M | -68.93%207.8M | -35.01%1.36B | 8.79%1.32B | 3.52%848.67M | 50.85%668.79M | -38.44%2.09B | -38.02%1.21B | -43.73%819.82M |
| Net cash flows from investing activities | 53.22%-387.69M | 31.49%-245.35M | 75.13%-44.76M | 59.94%-524.16M | -72.16%-828.71M | -19.71%-358.11M | -111.54%-180.01M | 44.37%-1.31B | 49.23%-481.37M | 33.32%-299.14M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 14.00%18.14M | -45.31%8.7M | ---- | -78.21%7.41M | 127.27%15.91M | 3,081.73%15.91M | --2.5M | -99.03%34M | -93.00%7M | -99.50%500K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | -78.21%7.41M | 127.27%15.91M | 3,081.73%15.91M | --2.5M | --34M | -93.00%7M | -99.50%500K |
| Cash from borrowing | 14.11%1.72B | -9.52%1.15B | -17.22%684.47M | 7.23%1.63B | 14.77%1.51B | 64.67%1.27B | 197.36%826.84M | -43.77%1.52B | -30.89%1.32B | -24.25%769.27M |
| Cash received relating to other financing activities | 18.28%1.13B | 9.95%831.77M | -68.99%234.14M | 294.89%1.46B | 2,442.41%954.48M | 9,816.06%756.5M | --755.16M | --369.68M | 29.53%37.54M | 156.06%7.63M |
| Cash inflows from financing activities | 15.71%2.87B | -2.58%1.99B | -42.03%918.61M | 60.87%3.1B | 82.38%2.48B | 162.31%2.04B | 469.84%1.58B | -69.00%1.93B | -33.09%1.36B | -30.50%777.4M |
| Borrowing repayment | 245.89%1.25B | 1,581.14%792.56M | 650.46%69.03M | -33.11%464.55M | -1.97%362.27M | -87.07%47.14M | -61.67%9.2M | -69.54%694.46M | -66.63%369.56M | -50.12%364.56M |
| Dividend interest payment | 15.15%80.39M | 38.48%58.32M | 45.98%35.83M | -57.96%89.23M | -64.79%69.81M | -77.75%42.12M | 114.89%24.54M | 5.05%212.27M | 2.68%198.29M | 3.74%189.3M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | -73.91%30.86K | --30.86K | --30.86K | --30.86K | --118.32K | ---- | ---- |
| Cash payments relating to other financing activities | 65.81%975.64M | -3.28%549.47M | -74.65%140.42M | 8.02%851.33M | 270.88%588.41M | 627.60%568.11M | 1,607.34%553.87M | 2,533.37%788.14M | 27.77%158.65M | 91.70%78.08M |
| Cash outflows from financing activities | 126.27%2.31B | 113.02%1.4B | -58.26%245.27M | -17.10%1.41B | 40.47%1.02B | 4.02%657.37M | 765.91%587.61M | -32.53%1.69B | -49.01%726.5M | -33.77%631.94M |
| Net cash flows from financing activities | -61.61%560.23M | -57.57%586.32M | -32.46%673.33M | 627.46%1.7B | 130.47%1.46B | 849.96%1.38B | 374.26%996.89M | -93.71%233.23M | 4.26%633.13M | -11.56%145.46M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | 103.42%569.52 | 103.42%569.52 | 2,882.33%676.93K | -2,765.02%-271.22K | ---16.67K | -2,920.35%-16.67K | --22.7K | ---9.47K |
| Net increase in cash and cash equivalents | 187.34%251.87M | 146.79%396.7M | -77.47%164.16M | 80.12%-81.29M | -145.33%-288.38M | -43.33%160.75M | 305.39%728.76M | -150.02%-408.79M | 203.46%636.12M | 176.07%283.65M |
| Add:Begin period cash and cash equivalents | -4.92%1.57B | -4.92%1.57B | -4.92%1.57B | -19.82%1.65B | -19.82%1.65B | -19.82%1.65B | -19.82%1.65B | 65.61%2.06B | 65.61%2.06B | 65.61%2.06B |
| End period cash equivalent | 33.61%1.82B | 8.52%1.97B | -27.11%1.74B | -4.92%1.57B | -49.40%1.37B | -22.66%1.81B | 6.25%2.38B | -19.82%1.65B | 327.98%2.7B | 168.89%2.35B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.